Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-024684
Filing Date
2025-08-19
Accepted
2025-08-18 19:06:03
Documents
58
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 735962
2 EX-31.1 ex31-1.htm EX-31.1 11940
3 EX-31.2 ex31-2.htm EX-31.2 11933
4 EX-32.1 ex32-1.htm EX-32.1 6911
5 EX-32.2 ex32-2.htm EX-32.2 6874
  Complete submission text file 0001641172-25-024684.txt   4535378

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE juns-20250630.xsd EX-101.SCH 36176
7 XBRL CALCULATION FILE juns-20250630_cal.xml EX-101.CAL 44561
8 XBRL DEFINITION FILE juns-20250630_def.xml EX-101.DEF 159190
9 XBRL LABEL FILE juns-20250630_lab.xml EX-101.LAB 359294
10 XBRL PRESENTATION FILE juns-20250630_pre.xml EX-101.PRE 276986
60 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 560994
Mailing Address 1001 NORTH US HWY 1 SUITE 504 JUPITER FL 33477
Business Address 1001 NORTH US HWY 1 SUITE 504 JUPITER FL 33477 (561) 406-6154
JUPITER NEUROSCIENCES, INC. (Filer) CIK: 0001679628 (see all company filings)

EIN.: 474828381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41265 | Film No.: 251229269
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)